Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009)

Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Fungi

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424935, 435911, C12N 100, C12N 114

Patent

active

057211345

ABSTRACT:
This invention relates to a strain, Ganoderma lucidum IY 009 which produces a proteoglycan G 009 possessed of antitumoral and immunostimulating effects, separated from the said cultured strain, containing: .beta.-glucose, .alpha.-glucose, galactose, .alpha.-mannose and fructose as saccharide components, and glycine, alanine, histidine, arginine, valine, aspartic acid, threonine, isoleucine, serine, leucine, glutamic acid, tyrocine, proline, phenylalanine and methionine as protein components. The Ganoderma lucidum IY 009 is deposited under accession number KCCM 10045.

REFERENCES:
patent: 4051314 (1977-09-01), Ohtsuka et al.
patent: 4145415 (1979-03-01), Akihiko
patent: 4472907 (1984-09-01), Wada et al.
patent: 5585467 (1996-12-01), Lee et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1874642

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.